Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: 83YOM0NEL5

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Sclerostin inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteoporosis 2 D010024 ClinicalTrials
Osteoporosis, Postmenopausal 1 D015663 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1742993
FDA SRS 83YOM0NEL5